Arecor Therapeutics (LON:AREC) Hits New 1-Year Low – Time to Sell?

Arecor Therapeutics plc (LON:AREC)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 47.95 ($0.62) and last traded at GBX 47.95 ($0.62), with a volume of 16492 shares changing hands. The stock had previously closed at GBX 49 ($0.63).

Arecor Therapeutics Stock Performance

The company has a market cap of £15.98 million, a P/E ratio of -1.50 and a beta of -0.18. The company has a 50 day moving average price of GBX 52.83 and a 200-day moving average price of GBX 65.28. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.

Arecor Therapeutics Company Profile

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.